These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23819188)

  • 21. Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs.
    Hawkey CJ; Hawkey GM; Everitt S; Skelly MM; Stack WA; Gray D
    Br J Clin Pharmacol; 2006 Jun; 61(6):730-7. PubMed ID: 16722837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More warnings about common pain relievers.
    Health News; 2005 Sep; 11(9):4. PubMed ID: 16211679
    [No Abstract]   [Full Text] [Related]  

  • 23. Pain drugs and heart attack. What's your risk?
    Mayo Clin Health Lett; 2013 Apr; 31(4):6. PubMed ID: 24696897
    [No Abstract]   [Full Text] [Related]  

  • 24. Idiosyncratic toxic hepatitis secondary to single dose of naproxen.
    Demirag MD; Ozenirler S; Goker B; Poyraz A; Haznedaroglu S; Ozturk MA
    Acta Gastroenterol Belg; 2007; 70(2):247-8. PubMed ID: 17715646
    [No Abstract]   [Full Text] [Related]  

  • 25. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
    Hermann M; Ruschitzka F
    Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yellow light on pain relievers. American Heart Association guidelines recommend using caution for all medications that ease pain.
    Harv Heart Lett; 2007 Jun; 17(10):1-3. PubMed ID: 17654797
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
    Hennekens CH; Borzak S
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
    van Staa TP; Rietbrock S; Setakis E; Leufkens HG
    J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose naproxen aggravates pancreatic fibrosis in a rat model of chronic pancreatitis.
    Zhang W; Gao J; Zhao T; Wu W; Bai Y; Zou D; Li Z
    Pancreas; 2010 Apr; 39(3):293-300. PubMed ID: 19823098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single nonsteroidal anti-inflammatory drug induced serum sickness-like reaction to naproxen in a patient able to tolerate both aspirin and ibuprofen.
    Koransky R; Ferastraoaru D; Jerschow E
    J Allergy Clin Immunol Pract; 2016; 4(1):160-1. PubMed ID: 26342741
    [No Abstract]   [Full Text] [Related]  

  • 31. [Developmental toxicity of naproxen].
    Burdan F; Sykut J; Przybylski P
    Pol Merkur Lekarski; 2007 Aug; 23(134):155-8. PubMed ID: 18044350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study results of routine clinical practice. Do rheumatism patients get substandard care?].
    MMW Fortschr Med; 2005 Nov; 147(47):63. PubMed ID: 16370199
    [No Abstract]   [Full Text] [Related]  

  • 35. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
    Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
    Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do NSAIDs actually protect against myocardial infarction and death?
    van Beers EJ; de Groot JR; Tijssen JG
    Clin Pharmacol Ther; 2009 Dec; 86(6):601-2; author reply 602-4. PubMed ID: 19865082
    [No Abstract]   [Full Text] [Related]  

  • 37. NSAIDs and your heart: risky or not?
    Health News; 2003 May; 9(5):7-8. PubMed ID: 12739460
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of selective and non-selective non-steroid anti-inflammatory drugs on secondary hemostasis in healthy volunteers.
    Schjerning O; Larsen TB; Damkier P
    Thromb Res; 2009 Jun; 124(2):208-12. PubMed ID: 19269020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal toxicity of over-the-counter analgesics.
    Dajani EZ
    Am J Gastroenterol; 1998 Jul; 93(7):1020-2. PubMed ID: 9672322
    [No Abstract]   [Full Text] [Related]  

  • 40. [Leukocytoclastic vasculitis associated with naproxen].
    Lossos IS; Yossepowitch O; Amir G; Orren R
    Harefuah; 1996 May; 130(9):600-1, 655. PubMed ID: 8794637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.